Highlights
NASDAQ: VKTX       Viking Thera
Last Price Today's Change   Day's Range   Trading Volume
7.34   +0.385 (5.54%)  6.95 - 7.35  1,331,200

Overview

 
Avg Volume (4 weeks):1,632,210
4 Weeks Range:6.86 - 8.56
4 Weeks Price Volatility (%):
28.24%
52 Weeks Range:6.15 - 11.03
52 Weeks Price Volatility (%):
24.39%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program, VK5211, is an orally available drug candidate, which is in Phase II clinical trial for acute rehabilitation following non-elective hip fracture surgery. Its second program is focused on the development of orally available small molecule thyroid hormone receptor beta agonists.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers